ADA holds near $0.17 after a strong rally as traders target $0.20, while Charles Hoskinson claims Ethereum is adopting ...
A research team at The Hong Kong Polytechnic University (PolyU) has developed Hong Kong's first "AI Agent for Precision ...
The U.S. SGLT2 Inhibitors Market is projected to grow from USD 5.49 Billion in 2025 to USD 11.06 Billion by 2035, while ...
Even with all the advances in technology, Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP, said patients ...
Today, the Obesity Association, a division of the American Diabetes Association® (the association), announced the next section in the Standards of Care in Overweight and Obesity, "Screening, Diagnosis ...
MiniMed automated insulin delivery and smart MDI systems can now be paired with Instinct and Instinct Go, made by Abbott, the smallest, longest-wear sensors in the company's portfolioNORTHRIDGE ...
Times of San Diego reviewed hundreds of medical records from inside the Otay Mesa detention center.
Pharmacy Times Continuing Education™ (PTCE) presented new research at the American Diabetes Association (ADA) 2026 Scientific Sessions, held June 5–8 in New Orleans, Louisiana. The ADA Scientific ...
Caliway's latest preclinical data on its proprietary localized fat reduction candidate, CBL-514, in combination with GLP–1R–based weightl ...
On 5 June, at the 86th Scientific Sessions of the American Diabetes Association (ADA) in New Orleans, Louisiana, findings were presented on the effects of Novo Nordisk's CagriSema on appetite, eating ...
I did not see the police officers muscle the five diabetes experts out of the convention center in New Orleans at the American Diabetes Association (ADA) meeting because I was inside the meeting room ...
Real-world data presented at ADA 2026 showcased the impact of Sanofi's teplizumab in slowing type 1 diabetes (T1D) progression.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results